By Professor Michael Leonard Friedlander

Journal articles

Quinn M; Murray J; Friedlander M; Steigrad S; Khoo S; Marsden D; Hammond I; Jobling T, 1994, 'EMACO in High Risk Gestational Trophoblast Disease ‐ The Australian Experience', Australian and New Zealand Journal of Obstetrics and Gynaecology, 34, pp. 90 - 92, http://dx.doi.org/10.1111/j.1479-828X.1994.tb01047.x

De Souza P; Friedlander M; Wilde C; Kirsten F; Ryan M, 1994, 'Hypersensitivity reactions to etoposide: A report of three cases and review of the literature', American Journal of Clinical Oncology: Cancer Clinical Trials, 17, pp. 387 - 389, http://dx.doi.org/10.1097/00000421-199410000-00005

Mayordomo JI; Paz-Ares L; Diaz-Puente MT; Lianes P; Garcia-Prats MD; Cortes-Funes H; Segelov E; Friedlander M, 1994, 'Prognostic factors for women with ovarian germ cell tumors [2]', Journal of Clinical Oncology, 12, pp. 1737 - 1738, http://dx.doi.org/10.1200/JCO.1994.12.8.1737

Mackintosh JF; Friedlander M; Lewis C; Goldstein D; Herrmann RP; Kearsley JH, 1994, 'Wanted: Guidelines for 'palliative' anti-cancer drug use [3]', Medical Journal of Australia, 161, pp. 638 - 639, http://dx.doi.org/10.5694/j.1326-5377.1994.tb127659.x

Lewis CR; Segelov E; Goldstein D; Friedlander ML, 1993, 'Chemotherapy made easier.', Australian and New Zealand journal of medicine, 23, pp. 387 - 392, http://dx.doi.org/10.1111/j.1445-5994.1993.tb01440.x

Leary JA; Doris CP; Boltz EM; Houghton CRS; Kefford RF; Friedlander ML, 1993, 'Investigation of loss of heterozygosity at specific loci on chromosomes 3p, 6q, 11p, 17p and 17q in ovarian cancer 11p, 17p and 17q in ovarian cancer', International Journal of Gynecological Cancer, 3, pp. 293 - 298, http://dx.doi.org/10.1046/j.1525-1438.1993.03050293.x

Leary JA; Edwards BG; Houghton CRS; Kefford RF; Friedlander ML, 1992, 'Amplification of HER-2/neu oncogene in human ovarian cancer', International Journal of Gynecological Cancer, 2, pp. 291 - 294, http://dx.doi.org/10.1046/j.1525-1438.1992.02060291.x

Levi JA; Wheeler HR; Friedlander M; Tattersall MHN; Kefford R; Dalley D, 1992, 'Dual sequential non-cross-resistant chemotherapy for advanced stage squamous cell carcinoma of the cervix', Gynecologic Oncology, 45, pp. 329 - 333, http://dx.doi.org/10.1016/0090-8258(92)90314-9

Chenevix-Trench G; Leary J; Kerr J; Michel J; Kefford R; Hurst T; Parsons PO; Friedlander M; Khoo SK, 1992, 'Frequent loss of heterozygosity on chromosome 18 in ovarian adenocarcinoma which does not always include the DCC locus', Oncogene, 7, pp. 1059 - 1065

De Souza PL; Friedlander ML, 1992, 'Prognostic factors in ovarian cancer', Hematology/Oncology Clinics of North America, 6, pp. 761 - 781, http://dx.doi.org/10.1016/s0889-8588(18)30309-5

Friedlander M; De Souza P; Segelov E, 1992, 'Risk factors, epidemiology, screening, and prognostic factors in female genital cancer', Current Opinion in Oncology, 4, pp. 913 - 922, http://dx.doi.org/10.1097/00001622-199210000-00016

Cope C; Rowe D; Delbridge L; Philips J; Friedlander M, 1991, 'Comparison of image analysis and flow cytometric determination of cellular DNA content', Journal of Clinical Pathology, 44, pp. 147 - 151, http://dx.doi.org/10.1136/jcp.44.2.147

Friedlander ML; Dembo AJ, 1991, 'Prognostic factors in ovarian cancer', Seminars in Oncology, 18, pp. 205 - 212

Cope C; Delbridge L; Philips E; Friedlander M, 1991, 'PROGNOSTIC SIGNIFICANCE OF NUCLEAR DNA CONTENT IN PHAEOCHROMOCYTOMA', Australian and New Zealand Journal of Surgery, 61, pp. 695 - 698, http://dx.doi.org/10.1111/j.1445-2197.1991.tb00323.x

Friedlander M, 1991, 'CURRENT GENITOURINARY CANCER SURGERY', Australian and New Zealand Journal of Medicine, 21, pp. 492 - 492, http://dx.doi.org/10.1111/j.1445-5994.1991.tb01367.x

Bishop JF; Kefford R; Raghavan D; Zalcberg J; Stuart-Harris R; Ball D; Olver IN; Friedlander M; Bull C; Yuen K; Matthews JP; Zimet A, 1990, 'Etoposide, carboplatin, cyclophosphamide and vincristine in previously untreated patients with small-cell lung cancer', Cancer Chemotherapy and Pharmacology, 25, pp. 367 - 370, http://dx.doi.org/10.1007/BF00686239

Boltz EM; Harnett P; Kefford RF; Leary J; Houghton R; Friedlander ML, 1990, 'Demonstration of somatic rearrangements and genomic heterogeneity in human ovarian cancer by DNA fingerprinting', British Journal of Cancer, 62, pp. 23 - 27, http://dx.doi.org/10.1038/bjc.1990.222

Bishop JF; Raghavan D; Olver IN; Reece P; Morris R; Friedlander ML, 1989, 'A phase I study of trimetrexate (NSC 352122) administered by 5-day continuous intravenous infusion', Cancer Chemotherapy and Pharmacology, 24, pp. 246 - 250, http://dx.doi.org/10.1007/BF00257627

Boltz EM; Kefford RF; Leary JA; Houghton CR; Friedlander ML, 1989, 'Amplification of c‐ras‐ki oncogene in human ovarian tumours', International Journal of Cancer, 43, pp. 428 - 430, http://dx.doi.org/10.1002/ijc.2910430314

Friedlander ML; Bell DR; Leary J; Davey RA, 1989, 'Comparison of Western blot analysis and immunocytochemical detection of P-glycoprotein in multidrug resistant cells', Journal of Clinical Pathology, 42, pp. 719 - 722, http://dx.doi.org/10.1136/jcp.42.7.719

Dalrymple JC; Bannatyne P; Russell P; Solomon HJ; Tattersall MHN; Atkinson K; Carter J; Duval P; Elliott P; Friedlander M; Murray J; Coppleson M, 1989, 'Extraovarian peritoneal serous papillary carcinoma. A clinicopathologic study of 31 cases', Cancer, 64, pp. 110 - 115, http://dx.doi.org/10.1002/1097-0142(19890701)64:1<110::AID-CNCR2820640120>3.0.CO;2-5

Boyer M; Friedlander M; Bannatyne P; Atkinson K, 1989, 'Hypercalcemia in association with mucinous adenocarcinoma of the ovary: A case report', Gynecologic Oncology, 35, pp. 387 - 390, http://dx.doi.org/10.1016/0090-8258(89)90085-1

Friedlander ML; Bell DR, 1989, 'Multidrug resistance: clinical findings and implications.', Cancer treatment and research, 42, pp. 63 - 77, http://dx.doi.org/10.1007/978-1-4613-1747-0_4

Friedlander ML; Quinn MA; Fortune D; Foo MS; Toppila M; Hudson CN; Russell P, 1989, 'The relationship of steroid receptor expression to nuclear DNA distribution and clinicopathological characteristics in epithelial ovarian tumors', Gynecologic Oncology, 32, pp. 184 - 190, http://dx.doi.org/10.1016/S0090-8258(89)80031-9

Antonjuk DJ; Boadle DK; Cheung HTA; Friedlander ML; Gregory PM; Tattersall MHN, 1989, 'α-Monoamides of methotrexate as potential prodrugs', Arzneimittel-Forschung/Drug Research, 39, pp. 12 - 15

Friedlander M; Leary J; Russelli P, 1988, 'An evaluation of CA125, CA1 and peanut lectin immunoreactivity in epithelial ovarian neoplasms: Correlation with histopathological features, prognostic variables and patient outcome', Pathology, 20, pp. 38 - 44, http://dx.doi.org/10.3109/00313028809085194

Solomon HJ; Atkinson KH; Coppleson JVM; Elliott PM; Houghton CRS; Murray J; Tattersall MHN; Friedlander ML; Green D, 1988, 'Ovarian carcinoma: Abdominopelvic irradiation following reexploration', Gynecologic Oncology, 31, pp. 396 - 401, http://dx.doi.org/10.1016/S0090-8258(88)80023-4

Friedlander ML; Hedley DW; Swanson C; Russell P, 1988, 'Prediction of long-term survival by flow cytometric analysis of cellular DNA content in patients with advanced ovarian cancer', Journal of Clinical Oncology, 6, pp. 282 - 290, http://dx.doi.org/10.1200/JCO.1988.6.2.282

Trebeck CE; Friedlander ML; Russell P; Baird PJ, 1987, 'Brenner tumours of the ovary: A study of the histology, immunohistochemistry and cellular dna content in benign, borderline and malignant ovarian tumours', Pathology, 19, pp. 241 - 246, http://dx.doi.org/10.3109/00313028709066557

KIRSTEN F; ATKINSON KH; COPPLESON JVM; ELLIOTT PM; GREEN D; HOUGHTON R; MURRAY JC; RUSSELL P; SOLOMON HJ; FRIEDLANDER M; SWANSON CE; TATTERSALL MHN, 1987, 'Combination chemotherapy followed by surgery or radiotherapy in patients with locally advanced cervical cancer', BJOG: An International Journal of Obstetrics & Gynaecology, 94, pp. 583 - 588, http://dx.doi.org/10.1111/j.1471-0528.1987.tb03154.x

Zalcberg JR; Friedlander ML; Minden MD, 1986, 'Molecular evidence for the clonal origin of blast crisis in chronic myeloid leukaemia', British Journal of Cancer, 53, pp. 459 - 464, http://dx.doi.org/10.1038/bjc.1986.73

Friedlander M; Zalcberg J; Patterson B; Minden M; Bergsagel DE, 1985, 'APPARENT T-CELL NEOPLASMS WITH IMMUNOGLOBULIN GENE REARRANGEMENTS', The Lancet, 326, pp. 670, http://dx.doi.org/10.1016/S0140-6736(85)90036-4

Taylor IW; Slowiaczek P; Friedlander ML; Tattersall MHN, 1985, 'Selective Toxicity of a New Lipophilic Antifolate, BW301U, for Methotrexate-resistant Cells with Reduced Drug Uptake', Cancer Research, 45, pp. 978 - 982

Hedley DW; Friedlander ML; Taylor IW, 1985, 'Application of DNA flow cytometry to paraffin‐embedded archival material for the study of aneuploidy and its clinical significance', Cytometry, 6, pp. 327 - 333, http://dx.doi.org/10.1002/cyto.990060409

Eckstein RP; Russell P; Friedlander ML; Tattersall MHN; Bradfield A, 1985, 'Metastasizing placental site trophoblastic tumor: A case study', Human Pathology, 16, pp. 632 - 636, http://dx.doi.org/10.1016/S0046-8177(85)80114-3

Friedlander ML; Russell P; Taylor IW; Tattersall MHN, 1985, 'Ovarian tumour xenografts in the study of the biology of human epithelial ovarian cancer', British Journal of Cancer, 51, pp. 319 - 333, http://dx.doi.org/10.1038/bjc.1985.44

Friedlander M; Foo MS; Quinn M, 1985, 'Relationship of steroid receptors and tumor ploidy in epithelial ovarian cancer', Proceedings of the American Association for Cancer Research, VOL. 26

Friedlander ML; Taylor IW; Russell P; Tattersall MH, 1984, 'Cellular DNA content—a stable feature in epithelial ovarian cancer', British Journal of Cancer, 49, pp. 173 - 179, http://dx.doi.org/10.1038/bjc.1984.29

Friedlander ML; Hedley DW; Taylor IW, 1984, 'Clinical and biological significance of aneuploidy in human tumours', Journal of Clinical Pathology, 37, pp. 961 - 974, http://dx.doi.org/10.1136/jcp.37.9.961

Hedley DW; Friedlander ML; Taylor IW; Rugg CA; Musgrove EA, 1984, 'DNA flow cytometry of paraffin‐embedded tissue', Cytometry, 5, pp. 660 - 660, http://dx.doi.org/10.1002/cyto.990050618

Friedlander ML; Russell P; Taylor IW; Hedley DW; Tattersall MHN, 1984, 'Flow cytometric analysis of cellular DNA content as an adjunct to the diagnosis of ovarian tumours of borderline malignancy', Pathology, 16, pp. 301 - 306, http://dx.doi.org/10.3109/00313028409068541

Hedley DW; Taylor IW; Coates AS; Tattersall MHN; Russell P; Friedlander ML, 1984, 'Influence of Cellular DNA Content on Survival in Advanced Ovarian Cancer', Cancer Research, 44, pp. 397 - 400

Friedlander ML, 1984, 'Prognostic Variables in Epithelial Ovarian Cancer: A Review', Australian and New Zealand Journal of Obstetrics and Gynaecology, 24, pp. 256 - 261, http://dx.doi.org/10.1111/j.1479-828X.1984.tb01506.x

Friedlander ML; Atkinson K; Coppleson JVM; Elliot P; Green D; Houghton R; Solomon HJ; Russell P; Tattersall MHN, 1984, 'The integration of chemotherapy into the management of locally advanced cervical cancer: A pilot study', Gynecologic Oncology, 19, pp. 1 - 7, http://dx.doi.org/10.1016/0090-8258(84)90150-1

Friedlander ML; Sims K; Kearsley JH, 1983, 'IMPAIRMENT OF RECALL IMPROVES TOLERANCE OF CYTOTOXIC CHEMOTHERAPY', The Lancet, 322, pp. 686, http://dx.doi.org/10.1016/S0140-6736(83)92568-0

Friedlander M; Kaye SB; Sullivan A; Atkinson K; Elliott P; Coppleson M; Houghton R; Solomon J; Green D; Russell P; Hudson CN; Langlands AO; Tattersall MHN, 1983, 'Cervical carcinoma: A drug-responsive tumor-experience with combined cisplatin, vinblastine, and bleomycin therapy', Gynecologic Oncology, 16, pp. 275 - 281, http://dx.doi.org/10.1016/0090-8258(83)90102-6

FRIEDLANDER ML; KEARSLEY JH; SIMS K; COATES A; HEDLEY D; RAGHAVAN D; FOX RM; TATTERSALL MHN, 1983, 'LORAZEPAM AS AN ADJUNCT TO ANTIEMETIC THERAPY WITH HALOPERIDOL IN PATIENTS RECEIVING CYTOTOXIC CHEMOTHERAPY', Australian and New Zealand Journal of Medicine, 13, pp. 53 - 56, http://dx.doi.org/10.1111/j.1445-5994.1983.tb04550.x

, 1983, 'Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry', Journal of Histochemistry and Cytochemistry, 31, pp. 1333 - 1335, http://dx.doi.org/10.1177/31.11.6619538

Friedlander ML; Taylor IW; Russell P; Musgrove EA; Hedley DH; Tattersall MHN, 1983, 'Ploidy as a prognostic factor in ovarian cancer', International Journal of Gynecological Pathology, 2, pp. 55 - 63, http://dx.doi.org/10.1097/00004347-198301000-00005

Taylor IW; Musgrove EA; Friedlander ML; Foo MS; Hedley DW, 1983, 'The influence of age on the DNA ploidy levels of breast tumours', European Journal of Cancer and Clinical Oncology, 19, pp. 623 - 628, http://dx.doi.org/10.1016/0277-5379(83)90178-5

Back to profile page